Goldman Sachs Says Value Stocks, Not Cyclicals, Would Rally Most on Vaccine
Bloomberg, 21 Sep 2020
Sep.21 -- A report by Goldman Sachs Group Inc. strategists, led by David Kostin, says value shares are a better way to bet on a Covid-19 vaccine than cyclical ...